Long-COVID symptoms persist for two years in over half of cases

23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long-COVID, and in more than half of them the symptoms persisted for two years.

HHS Unveils Data Strategy to Fuel Cancer Moonshot

What You Should Know: – The U.S. Department of Health and Human Services (HHS) has released its comprehensive Data Strategy, outlining a vision for leveraging

December 15, 2023

Ascletis Pharma scraps liver disease program; Another reverse merger

Plus, news about BenevolentAI, Adaptive Biotechnologies, Eisai, CNX Therapeutics, Vanda Pharmaceuticals and Nucleai: Ascletis Pharma ends liver disease program: The Chinese biotech will not pursue

April 4, 2024

Gene therapy to prevent stillbirth and premature delivery developed

Researchers investigate the effectiveness of placental nano-based insulin-like 1 growth factor gene therapy to correct fetal growth restriction.

December 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.